Tag Archives: digital marketing

Focusing On the Metrics That Matter: A Quick Guide to Marketing Analytics

The medicines business is all about data. Drug discovery relies on the meticulous interpretation of experimental results; clinical trials involve carefully analysing streams of information relating to patient response; even physician decision-making around the most appropriate therapies is becoming more and more data driven. There is no question, data is big on the science side […]
Posted in E-Media, Europe, Global, Marketing, multimedia, Technology | Also tagged , | Leave a comment

Lack of Multichannel Confidence: A Step on the Road to Digital Maturity

I’ve been lucky enough to get a sneak preview of Across Health’s 2014 Multichannel Barometer report. This is the sixth year the Belgium-based digital consultancy has conducted its Barometer survey and it’s interesting to look at the progress, or lack thereof, across the years. The data collected for last year’s survey led Across CEO Fonny […]
Posted in E-Media, Europe, Guest Blog, Marketing, multimedia, Op-Ed, Technology | Also tagged , | Leave a comment

Making the Most of Disruptive Digital Technologies

Peter Houston looks at the pharma marketing takeaways from last week’s Digital Innovation Summit.
Posted in E-Media, Europe, Events, Global, Marketing, multimedia, Op-Ed, social media, Technology | Also tagged , , | Leave a comment

Digital Summit Preview: Improving Brand Engagement

It’s no secret that the use of digital marketing in the life sciences industry has evolved considerably in recent years. The tools and strategies necessary for pharma brand teams to effectively engage with an increasingly more educated and informed consumer pool are seemingly advancing, or at least being modified, regularly. Throw in other factors such […]
Posted in Events, Marketing, multimedia, Strategy | Also tagged , , | Leave a comment

FDA Guidances, OIG Investigations to Shape Drug Marketing, Research

Marketers may see further advice from the Food and Drug Administration in the coming year that clarifies how they can use social media. Priority topics:  presenting risk and benefit information in limited space; correcting independent/third party misinformation about a drug or medical device; and appropriate use of links, according to the agenda for the Center […]
Posted in Advertising, Biotech, E-Media, FDA, Legal, pricing, Regulatory, social media | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta